Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXPQ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,647
Award facts
- Contract value 100% obligated
- $22,647.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,647.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Dupixent 300 mg/2 mL pens. The contract, which represents a competitive award with no set-aside designation, is scheduled for completion by December 9, 2025, with performance to occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive federal contract portfolio with the Defense Logistics Agency covering a diverse range of pharmaceutical products and medical supplies. The company's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its established infrastructure and relationship with the military healthcare system, positions it as a critical vendor for supporting Defense Health Agency and related government healthcare operations. Dupixent is a prescription biologic medication indicated for multiple allergic and inflammatory conditions, and this delivery order fulfills DLA's pharmaceutical supply requirements for military healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FXPQ4?
SPE2DR26FXPQ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FXPQ4 worth?
The government has obligated $22,647 on SPE2DR26FXPQ4.
Is contract SPE2DR26FXPQ4 an order under another contract?
Yes. SPE2DR26FXPQ4 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXPQ4 competed?
The extent of competition for SPE2DR26FXPQ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award